( APAR )
Advancing One Health Security Capacities in the Global South
Who we are
After recent outbreaks of EBOLA, Lassa, Zika, Plague, MERS-COV, COVID-19 isthe latest zoonotic epidemic that has infected >40 Mil people and resulted in more than 1,200,000 deaths with the numbers growing every day. These zoonotic outbreaks and those that will inevitably happen in the future, have illustrated the importance of strengthening coordinated one health security preparedness of regional response networks.These networks are essential to assure timely notification, prepare for, mitigate and respond to the threat of transboundary impact & proliferation of pathogens and diseases. In particular, as infectious diseases are mostly emerging in the southern hemisphere, they particularly affect human, veterinary and environmental health in the global south disproportionately.
On February 28th, 2019 at the New Delhi One Health India Conference, recognizing the continuing global threat and burden of zoonotic diseases, experts and representatives from 28 countries supported and signed a declaration that calls for establishing a global network that can effectively respond to this threat. Now, in response to this call for action the global Alliance for Pandemic Preparedness and Response (APAR) is being launched to address that critical need. APAR, as an independent entity, will catalyze South-South Cooperation (SSC) to holistically and sustainably advance health and bio-security capacities in the global south whilefacilitating the health security dialogue with the North.
Our Focus Area
Our focus areas are leveraged on a Holistic Framework for Building Comprehensive Health Security Capacities for the Global South through multisectoral and multidisciplinary coordination at South/South and North/South engagement level.
Inform Bio Economy Preparedness and Stakeholder Engagement
Facilitate Creation of Advisory Councils to Governments
- Focus on mitigation of the cascading impacts of pandemics on economies
Biotechnology Response Networks
- Establish bio tech industry networks that can synergistically scale innovation and production (therapeutics, reagents, vaccines) in times of crisis.
- Identify Pharmaceutical response platforms that can rapidly repurpose existing therapeutics and advance innovation partnerships.